| Document Date: 2012-08-14 05:05:18 Open Document File Size: 34,51 KBShare Result on Facebook
City Les Ulis / Paris / / Company LFB Biotechnologies S.A.S. / GTC BIOTHERAPEUTICS GTC / GTC Biotherapeutics Inc. / LFB Group / Press releaseGTC BIOTHERAPEUTICS Inc. / / Continent Europe / / Country France / United States / / Currency EUR / / / Event Patent Issuance / FDA Phase / / IndustryTerm biopharmaceutical / treatment of serious and often rare diseases / therapeutic proteins / therapeutic product / transgenic animal technology / plasma-derived medicinal products / recombinant production systems / biopharmaceutical industry / medicinal products / health technologies / / MedicalCondition often rare diseases / III deficiency / inflammation / / MedicalTreatment innovative therapies / / Organization EMA / United States Patent and Trademark Office / FDA / / Person William Heiden / Christian Bechon / / / Position CEO / leader / Director of Communication Tel / / Product S.A.S / ATryn® / / Technology transgenic protein production / transgenic animal technology / health technologies / antibodies / medicinal products / / URL http /
SocialTag |